Previous 10 | Next 10 |
home / stock / immvf / immvf news
Immunovia press release (OTCPK:IMMVF): Q1 GAAP EPS of -SEK 1.95. Revenue of SEK 0.18M (+50.0% Y/Y). For further details see: Immunovia GAAP EPS of -SEK 1.95, revenue of SEK 0.18M
Immunovia press release (OTCPK:IMMVF): FY GAAP EPS of -SEK6.89. Revenue of SEK0.84M (+133.3% Y/Y). For further details see: Immunovia GAAP EPS of -SEK6.89, revenue of SEK0.84M
Immunovia AB (publ) (IMMVF) Q1 2021 Results Earnings Conference Call April 28, 2021, 10:30 am ET Company Participants Patrik Dahlen - Chief Executive Officer Conference Call Participants Lars Hevreng - Danske Alex Cogut - Kempen Viktor Sundberg - ABG Sundal Collier Presentation Operator Hello...
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test PR Newswire LUND, Sweden , April 22, 2021 /PRNewswire/ -- Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test (LDT) in Q2 2021. The ...
Immunovia reports improved test performance of IMMrayTM PanCan-d in detecting early stage pancreatic cancer in high risk symptomatic patients Stage I/II pancreatic cancer was detected with a specificity of 92% and a sensitivity of 80% in a clinical study PR Newswire ...
Immunovia AB (publ) (IMMVF) Q4 2020 Earnings Conference Call February 17, 2021, 10:30 AM ET Company Participants Patrik Dahlen - CEO Conference Call Participants Viktor Sundberg - ABG Alex Cogut - Kempen Felicia Rittemar - Vator Securities Presentation Operator Welcome to the Immunovia Q4 Con...
Immunovia (IMMVF): FY GAAP EPS of $6.84.Revenue of $0.36M (flat Y/Y)Press Release For further details see: Immunovia reports FY results
Immunovia's PanFAM-1 Prospective Study Gathers Over 3000 Familial Hereditary Pancreatic Cancer Risk Samples And Will Be Analysed In The Second Half Of 2021 PR Newswire LUND, Sweden , Feb. 15, 2021 /PRNewswire/ -- According to the American Cancer Society, as many ...
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants PR Newswire LUND, Sweden , Jan. 19, 2021 /PRNewswire/ -- Immunovia AB, ("Immunovia") announces today that Patrik Dahlen , CEO of Immunovia, has purchased 250,000 warrants of the 2020/2024...
Proteomic data derived from Immunovia's IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases PR Newswire LUND, Sweden , Jan. 7, 2021 /PRNewswire/ -- I mmunovia AB, ("Immunovia") a diagnostic company that deve...
News, Short Squeeze, Breakout and More Instantly...
Immunovia AB Company Name:
IMMVF Stock Symbol:
OTCMKTS Market:
Immunovia Publishes Interim Report for January-March 2023 PR Newswire LUND, Sweden , May 23, 2023 /PRNewswire/ -- January- March 2023 Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). N...
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states PR Newswire LUND, Sweden , May 23, 2022 /PRNewswire/ -- T...
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test PR Newswire LUND, Sweden , April 22, 2021 /PRNewswire/ -- Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test (LDT) in Q2 2021. The ...